Abstract
Method of treating endometriosis and related indications, comprising the administration of Pro-EGCG, a synthetic and derivative product of epigallocatechin-3-gallate [(−)-EGCG]. Use of PRO-EGCG in the manufacture of a medicament for treating endometriosis and related indications. Pro-EGCG for use in the treatment of endometriosis and related indications.
Original language | English |
---|---|
Patent number | US11045445 |
Filing date | 4/05/20 |
Publication status | Published - 29 Jun 2021 |